Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;64(3):e305-e307.
doi: 10.1111/ajd.14097. Epub 2023 Jun 6.

Dupilumab in paediatric Netherton syndrome: Can we do better?

Astrid Herzum  1 , Corrado Occella  1 , Lodovica Gariazzo  1 , Clelia Formigoni  2 , Gianmaria Viglizzo  1
Affiliations

Dupilumab in paediatric Netherton syndrome: Can we do better?

Astrid Herzum et al. Australas J Dermatol. 2023 Aug.
No abstract available

Keywords: Netherton; atopic dermatitis; dupilumab; genodermatosis; quality of life.

PubMed Disclaimer

References

REFERENCES

    1. Özkaya E, Günay MB, Babuna Kobaner G, Keskinkaya Z, Gökalp MO. Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: case report and review of the literature. Australas J Dermatol. 2023;64:272-7. https://doi.org/10.1111/ajd.13986
    1. Herz-Ruelas ME, Chavez-Alvarez S, Garza-Chapa JI, Ocampo-Candiani J, Cab-Morales VA, Kubelis-López DE. Netherton syndrome: case report and review of the literature. Skin Appendage Disord. 2021;7:346-50. https://doi.org/10.1159/000514699
    1. Le Floc'h A, Allinne J, Nagashima K, Scott G, Birchard D, Asrat S, et al. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation. Allergy. 2020;75:1188-204. https://doi.org/10.1111/all.14151
    1. Malik K, He H, Huynh TN, Tran G, Mueller K, Doytcheva K, et al. Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature. J Allergy Clin Immunol. 2019;143:604-18. https://doi.org/10.1016/j.jaci.2018.03.021
    1. Luchsinger I, Knöpfel N, Theiler M, Bonnet des Claustres M, Barbieux C, Schwieger-Briel A, et al. Secukinumab therapy for Netherton syndrome. JAMA Dermatol. 2020;156:907-11. https://doi.org/10.1001/jamadermatol.2020.1019

LinkOut - more resources